Published: 2021-11-10

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just

(184-189)

DOI: https://doi.org/10.5152/eurjrheum.2021.20054

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases

Cosimo Bruni, Cosimo Cigolini, Giulia Tesei, Laura Cometi, Francesca Bartoli, Ginevra Fiori, Francesca Nacci, Silvia Bellando-Randone, Serena Guiducci, Marco Matucci-Cerinic

(190-195)

DOI: https://doi.org/10.5152/eurjrheum.2020.21162

Ginger extract suppresses the activations of NF-κB and Wnt pathways and protects inflammatory arthritis

Burak Öz, Cemal Orhan, Mehmet Tuzcu, Nurhan Şahin, İbrahim Hanifi Özercan, Pınar Demirel Öner, Süleyman Serdar Koca, Vijaya Juturu, Kazım Şahin

(196-201)

DOI: https://doi.org/10.5152/eujrheum.2020.20192

What do patients with rheumatoid arthritis know about their own biomedical data related to cardiovascular disease risks?

Tanaka Ngcozana, Kevin Corbett, Ajay Bhatia

(202-206)

DOI: https://doi.org/10.5152/eurjrheum.2021.20021

The association of anti-CD74 antibody with spondyloarthropathies

Seda Çolak, Tahsin Murat Turgay, Orhan Küçükşahin, Mustafa Türker Duman, Hülya Çetinkaya, Murat Toruner

(207-210)

DOI: https://doi.org/10.5152/eurjrheum.2021.20090

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients

Cemal Gürbüz, Demet Yalçın Kehribar, Metin Özgen

(211-216)

DOI: https://doi.org/10.5152/eurjrheum.2020.21199

Central nervous system vasculitis in a patient with axial spondyloarthritis treated with infliximab: A case report and literature review

Panagiotis Panagopoulos, Gkikas Katsifis

(228-231)

DOI: https://doi.org/10.5152/eurjrheum.2021.20071

Biologic treatments in Behçet’s disease

Fatma Alibaz-Öner, Haner Direskeneli

(217-222)

DOI: https://doi.org/10.5152/eurjrheum.2020.20138

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Yusuf Karabulut

(223-227)

DOI: https://doi.org/10.5152/eurjrheum.2021.20160

Declining in-hospital mortality in vasculitis: A 17-year US national study

Jasvinder A. Singh, John D. Cleveland

(232-234)

DOI: https://doi.org/10.5152/eurjrheum.2021.20116

Syringomyelia presenting as neuropathic arthropathy of basal and shoulder joints

Ganesh Singh Dharmshaktu

(235-236)

DOI: https://doi.org/10.5152/eurjrheum.2020.20053

Palmoplantar keratoderma as the preceding cutaneous manifestation of juvenile-onset dermatomyositis

Pratap Kumar Patra, Aaqib Zaffar Banday, Robin Bansal, Murugan Sudhakar, Ankur Kumar Jindal

(237-238)

DOI: https://doi.org/10.5152/eurjrheum.2020.20068